Viewing Study NCT05972967


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-11 @ 3:37 AM
Study NCT ID: NCT05972967
Status: COMPLETED
Last Update Posted: 2025-10-01
First Post: 2023-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab
Sponsor: Omeros Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module